MS activity not likely to be affected by dairy or gluten foods, study finds
An analysis of data covering nearly 200 people with multiple sclerosis (MS) found no association between dairy or gluten…
Articles by Marisa Wexler, MS
Top 10 MS stories of 2023
Throughout 2023, Multiple Sclerosis News Today brought consistent coverage to our readers of the latest scientific research, developments in…
Talk therapy found to ease fatigue in MS – with or without follow-up
A 20-week talk therapy program led to significant reductions in fatigue for people with multiple sclerosis (MS) — benefits…
NK cells may hold key to link between viral infections, MS
Natural killer (NK) cells, a type of immune cell, are critical for preventing an immune response against an infecting virus…
Vitamin B12 transport system can carry Gilenya into the brain: Study
The molecular process that brings vitamin B12 into the brain can also transport Gilenya (fingolimod), an approved treatment for…
Novel compound ZCAN262 restores lost myelin in MS mouse models
A novel compound that can lessen toxic overactivation of nerve cells was found to significantly reduce disease activity and restore…
Mediterranean diet linked to better mental health in older MS patients
Elderly adults with multiple sclerosis (MS) who adhere more to a Mediterranean diet tend to have less severe disability…
Phase 3 studies of BTK inhibitor evobrutinib fail to meet main goal
The Phase 3 EVOLUTION clinical trials have failed to demonstrate that evobrutinib is more effective than the approved medication…
Essential oils from pumpkins, green tea reduce brain damage in MS rats
Treatment with essential oils derived from green tea or pumpkin reduced brain damage in a rat model of multiple…
Trial testing metformin, alpha-lipoic acid in progressive MS set to start
A new clinical trial in Australia, called PLATYPUS, will simultaneously test two medications that have already been approved for…
Stem cell therapy well tolerated in SPMS clinical trial
A novel therapy in which neural stem cells are injected into the brain was well tolerated by 15 people with…
Stopping DMT use tied to greater long-term disability in MS database
People with multiple sclerosis (MS) who discontinue a disease-modifying treatment are more likely to have greater long-term disability…
FDA clears AI tool for detecting disease activity on MRI scans
Pixyl.Neuro, a next-generation software that uses artificial intelligence (AI) in analyzing MRI scans to help detect and monitor…
HHV-6A herpes virus tied to more nerve damage before onset of MS
Infection with a herpes virus known as HHV-6A is associated with significantly higher levels of the nerve damage biomarker neurofilament…
CSF protein levels at diagnosis may help predict MS long-term outcomes
Levels of proteins in the liquid that surrounds the brain and spinal cord, called the cerebrospinal fluid (CSF), can help…
ATA188 fails to outperform placebo in EMBOLD clinical trial
ATA188, an experimental cell therapy targeting the Epstein-Barr virus, failed to outperform a placebo at easing disability levels in…
Online brain training games improved cognition in small MS trial
The use of a computer-based program called BrainHQ led to significantly improved scores on cognitive tests among people with…
High blood NfL levels predict greater MS disability in year or two: Study
Elevated blood levels of neurofilament light chain (NfL), an established biomarker of nerve damage, are associated with a higher risk…
Blocking NLRP3 inflammasome eases MS severity in mouse model
Blocking the activity of a protein complex called the NLRP3 inflammasome lessened disease severity in a mouse model of…
AI tool has potential to better track MS lesions over time: Study
An artificial intelligence (AI) program, called iQ-MS, outperforms traditional radiologist-based measures at quantifying changes in lesions over time in people…
Study: Some types of MS pain make exercise more difficult
Chronic pain can make it harder for people with multiple sclerosis (MS) to be physically active, but some types…
Circadian rhythm of certain stem cells may offer treatment approach
Targeting genes that control the daily activity cycle of cells that are responsible for repairing myelin in the brain and…
African American MS patients have high B-cell levels in CSF, study says
People with multiple sclerosis (MS) of African descent had higher levels of inflammatory B-cells in the fluid around the…
Immune cell, fat metabolism changes may help explain MS progression
More activity among certain immune cells, as well as differences in immune signaling molecules, iron regulation, and fat metabolism, may…
Gut bacteria can differ among MS patients by genetic disease risk
People with a higher genetic risk for multiple sclerosis (MS) were seen to have detectable differences in their gut…
NEDA 3 and 4 ‘hard to achieve’ with relapsing MS, real-world study finds
Achieving NEDA — no evidence of disease activity — after two years of treatment was not common among people with…
Costs of ‘COVID-19 gap’ in MS expected to top $500M in Canada
The overall financial impact of changes in treatment and delayed diagnoses for people with multiple sclerosis (MS) in Canada…
Machine learning used to estimate when brain shrinkage begins
Brain atrophy (shrinkage) in people with multiple sclerosis (MS) begins on average more than five years before disease…
ECTRIMS 2023: Foralumab seen to ease brain inflammation in SPMS
Six months of treatment with foralumab, administered into the nose, led to decreases in microglial activity in five of six…
ECTRIMS 2023: New research may help explain EBV and MS link
New research by scientists in Austria may shed light on the link between the Epstein-Barr virus (EBV) and multiple sclerosis…